Brain-Derived Neurotrophic Factor in Multiple Sclerosis Disability: A Prospective Study.
BDNF
brain-derived neurotrophic factor
demyelinating disease
immunomodulating agents
interferons
magnetic resonance imaging
multiple sclerosis
neurologic manifestations
teriflunomide
Journal
Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646
Informations de publication
Date de publication:
29 Feb 2024
29 Feb 2024
Historique:
received:
02
02
2024
revised:
22
02
2024
accepted:
28
02
2024
medline:
28
3
2024
pubmed:
28
3
2024
entrez:
28
3
2024
Statut:
epublish
Résumé
Multiple sclerosis (MS) is a demyelinating central nervous system disease that leads to neurological disability. Brain-derived neurotrophic factors (BDNFs) are neurotrophins involved in neurodegenerative disorders. This study analysed the relationship between serum BDNF, neurological disability and different MS treatments. We included 63 people with MS (PwMS), with relapsing-remitting MS or clinically isolated syndrome, and 16 healthy controls (HCs). We analysed the serum levels of BDNF and MS specific disability tests (Expanded Disability Status Scale, timed 25-foot walk test, nine-hole peg test), at baseline (V0) and after one year of interferon beta1a or teriflunomide treatment (V1). Baseline BDNF values were not different between the PwMS and HCs (
Identifiants
pubmed: 38539631
pii: brainsci14030243
doi: 10.3390/brainsci14030243
pii:
doi:
Types de publication
Journal Article
Langues
eng